Our team members are at the heart of everything we do. At Cencora, we are united in our responsibility to create healthier futures, and every person here is essential to us being able to deliver on
Do you value integrity and innovation? How about passion and caring? Great! Us too, and thats why youll fit right in. Our intentional culture promotes trust and participation, encouraging you to bring your heart and mind
Curriculum Specialist, Nursing Graduate Program Primary Purpose: The purpose of this position is to support the College of Nursing Graduate Programs’ Review. Nature of Work: The Curriculum Specialist will work with the Associate Dean Research and
Who We Are Rising Edge Group is an electrical contracting company founded in 2002, specialization in high-voltage electrical solutions that power critical infrastructure across North America. With operations in both Canada and the United States, we
Why Ryan? Hybrid and Remote Work Options Award-Winning Culture Generous Personal Time Off (PTO) Benefits Up to 20 Weeks of Parental Leave Top-up (Adoption Included Monthly Gym Membership OR Gym Equipment Reimbursement Health and Dental Benefit
Company: CLIC Department: Group Benefits Employment Type: Regular Full-Time Work Model: Hybrid (2 days in office) Language: This role operates in English. Additional Information: This/these role(s) is/are currently vacant The Opportunity: We are a leading Canadian
Empowering lives, healing hearts, embracing future Are you ready to make a lasting impact on specialty care? We’re seeking a dedicated and dynamic Registered Pharmacy Technician to join our #BestTeam at BioScript Pharmacy, where we put
Work Location Type: Remote About Grainger W.W. Grainger, Inc. is a leading broad line distributor with operations primarily in North America and Japan. At Grainger, We Keep the World Working® by serving more than 4.6 million
HistoSonics is a commercial-stage medtech company advancing the Edison® System, a novel non-invasive sonic beam therapy based on histotripsy. Since receiving FDA De Novo grant for the non-invasive destruction of liver tumors in 2023, the company